Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Protalix Biotherapeutics Inc V.PLX.H


Primary Symbol: PLX

Protalix BioTherapeutics, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of recombinant therapeutic proteins expressed through its proprietary plant cell-based expression system, ProCellEx. In addition, the Company is developing PEGylated uricase, or PRX-115, for the treatment of severe gout, Long Acting (LA) DNase I, or PRX-119, for the treatment of NETs-related diseases, and other technologies and preclinical assets. Its product, Elelyso is an enzyme replacement therapy (ERT) for the treatment of patients with Gaucher disease. Its ProCellEx platform is being used to manufacture both of its approved and marketed products as well as PRX-115 and PRX-119. PRX-115, a plant cell-expressed recombinant PEGylated Uricase (urate oxidase)- a chemically modified enzyme under development for the potential treatment of severe gout. PRX-119 is a plant cell-expressed PEGylated recombinant human DNase I product candidate.


NYSEAM:PLX - Post by User

Post by mike49on Jul 12, 2017 11:44pm
291 Views
Post# 26463210

So evenready is big player

So evenready is big playerGeorge,pay attention.
 
 
You are logged in: Mot49 
 
Pengrowth Energy Corp
Symbol C : PGF
Shares Issued 552,253,560
Close 2017-07-11 C$ 0.99
Recent Sedar Documents

 

Globe says Pengrowth scraps sale of oil assets

 

2017-07-12 08:03 ET - In the News

 

The Globe and Mail reports in its Wednesday edition that Pengrowth Energy (99 cents) has scrapped a $180-million deal to sell Alberta oil assets to a private company backed by a Chinese-Thai billionaire after financing for the transaction fell through. The Globe's Jeff Lewis writes that the move is a setback for Pengrowth as it tries to patch up its finances. Pengrowth did not disclose the buyer involved in the failed acquisition of properties in the Swan Hills region of northwest Alberta. However, sources said it was Grand Valley Resources, a private start-up company backed by the Reignwood Group, itself led by Chinese-Thai businessman Chanchai Ruayrungruang. Reignwood's best-known assets include an eponymous office complex in central Beijing as well as the Chinese rights to Red Bull energy drink. Mr. Ruayrungruang is one of several wealthy Chinese executives scouting for deals in Canada's downtrodden energy industry. More than $3-billion of private Chinese capital has entered the oil patch, often targeting distressed assets and companies in a takeover binge that has largely escaped public notice. The influx has also helped banks stem losses on soured loans to heavily

As side note,maybe razor gets another kick at the cat.
Stay safe all
<< Previous
Bullboard Posts
Next >>